BSE Live
Oct 17, 16:01Prev. Close
921.35
Open Price
922.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 15:57Prev. Close
921.75
Open Price
914.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
927.20 (18)
Key Financial Ratios of Windlas Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 29.03 | 27.95 | 19.71 | 18.81 | 2.75 | |
Diluted EPS (Rs.) | 28.71 | 27.86 | 19.71 | 18.81 | 2.75 | |
Cash EPS (Rs.) | 42.29 | 34.42 | 26.29 | 23.27 | 28.04 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 241.31 | 216.51 | 192.42 | 181.30 | 310.39 | |
Book Value [InclRevalReserve]/Share (Rs.) | 241.31 | 216.51 | 192.42 | 181.30 | 310.39 | |
Dividend / Share(Rs.) | 5.80 | 5.50 | 4.00 | 3.50 | 0.00 | |
Revenue from Operations/Share (Rs.) | 362.54 | 303.37 | 245.19 | 213.79 | 666.98 | |
PBDIT/Share (Rs.) | 53.32 | 44.03 | 33.55 | 27.35 | 90.14 | |
PBIT/Share (Rs.) | 39.97 | 37.56 | 27.64 | 21.77 | 69.91 | |
PBT/Share (Rs.) | 37.88 | 37.03 | 27.27 | 21.12 | 17.44 | |
Net Profit/Share (Rs.) | 28.94 | 27.96 | 20.38 | 17.69 | 7.81 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 14.70 | 14.51 | 13.68 | 12.79 | 13.51 | |
PBIT Margin (%) | 11.02 | 12.38 | 11.27 | 10.18 | 10.48 | |
PBT Margin (%) | 10.44 | 12.20 | 11.12 | 9.88 | 2.61 | |
Net Profit Margin (%) | 7.98 | 9.21 | 8.31 | 8.27 | 1.17 | |
Return on Networth / Equity (%) | 11.99 | 12.91 | 10.59 | 9.75 | 2.51 | |
Return on Capital Employed (%) | 16.39 | 17.17 | 14.17 | 11.94 | 22.12 | |
Return on Assets (%) | 7.97 | 9.28 | 8.06 | 7.85 | 1.69 | |
Total Debt/Equity (X) | 0.05 | 0.00 | 0.00 | 0.02 | 0.15 | |
Asset Turnover Ratio (%) | 1.10 | 1.09 | 1.01 | 1.18 | 1.34 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.11 | 2.52 | 2.92 | 4.07 | 2.08 | |
Quick Ratio (X) | 1.78 | 2.15 | 2.31 | 3.45 | 1.63 | |
Inventory Turnover Ratio (X) | 10.52 | 5.65 | 5.11 | 6.14 | 5.96 | |
Dividend Payout Ratio (NP) (%) | 18.95 | 14.30 | 17.88 | 19.77 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 12.96 | 11.62 | 13.86 | 15.04 | 0.00 | |
Earnings Retention Ratio (%) | 81.05 | 85.70 | 82.12 | 80.23 | 0.00 | |
Cash Earnings Retention Ratio (%) | 87.04 | 88.38 | 86.14 | 84.96 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 2,193.55 | 1,034.80 | 446.24 | 350.21 | 0.00 | |
EV/Net Operating Revenue (X) | 2.89 | 1.64 | 0.87 | 0.75 | 0.00 | |
EV/EBITDA (X) | 19.63 | 11.30 | 6.36 | 5.88 | 0.00 | |
MarketCap/Net Operating Revenue (X) | 2.87 | 1.69 | 0.92 | 0.98 | 0.00 | |
Retention Ratios (%) | 81.04 | 85.69 | 82.11 | 80.22 | 0.00 | |
Price/BV (X) | 4.31 | 2.37 | 1.17 | 1.16 | 0.00 | |
Price/Net Operating Revenue | 2.87 | 1.69 | 0.92 | 0.98 | 0.00 | |
Earnings Yield | 0.03 | 0.05 | 0.09 | 0.08 | 0.00 |
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
23.05.2025
Windlas Biotech Standalone March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
17.02.2025
Windlas Biotech Standalone December 2024 Net Sales at Rs 195.02 crore, up 20.22% Y-o-Y